Results 201 to 210 of about 242,018 (254)

Economic Evaluation of Bruton's Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukaemia in South Africa. [PDF]

Appl Health Econ Health Policy
Woudberg R, Sinanovic E.
europepmc   +1 more source

TP53-aberrated CLL: is BTK inhibitor monotherapy enough? [PDF]

Blood Adv
Niemann CU.
europepmc   +1 more source

Accelerated Chronic Lymphocytic Leukaemia Complicated by Bilateral Pathological Humeral Fractures. [PDF]

EJHaem
Khawar M, Bashkirova V, Manohar V, Dhanapal J.   +3 more
europepmc   +1 more source

Richter transformation to classical Hodgkin lymphoma following recurrent disseminated histoplasmosis in chronic lymphocytic leukemia: a Case Report. [PDF]

Front Oncol
Haj D, Said M, Al-Assil T, Stone S, Omaira M.   +4 more
europepmc   +1 more source

CLL / myeloma

Annals of Oncology, 2011
openaire   +1 more source

Post-treatment infection prediction in CLL using domain adaptation of lymphoma electronic health records. [PDF]

Acta Oncol
Parviz M, Brieghel C, Werling M, Lacoppidan T, Rotbain E, Niemann CU, Agius R.   +6 more
europepmc   +1 more source

Case Report: renal allograft infiltration by chronic lymphocytic leukemia successfully treated with zanubrutinib. [PDF]

Front Oncol
Abboud B, Rodriguez NG, Babar A, Coreas N, Robbins K, Kunwor R.   +5 more
europepmc   +1 more source

Authors' reply to: Interpretable multi-task prediction in rhabdomyolysis: promise and caveats. [PDF]

EClinicalMedicine
Liu C, Shi J, Wang F, Li D, Luo Y, Yang B, Zhao Y, Zhang L, Yang D, Jin H, Song J, Guo X, Fan H, Lv Q.   +13 more
europepmc   +1 more source